Dr. William Slayton, MD
Claim this profileUniversity of Florida Health Science Center - Gainesville
Expert in Tumors
Expert in Lymphoma
57 reported clinical trials
107 drugs studied
About William Slayton, MD
Education:
- Earned an MD (Doctor of Medicine) from the University of Florida Health Science Center - Gainesville.
Experience:
- Served as the Pediatrics Hem/Onc (Hematology/Oncology) Clerkship Director for Medical Students during the academic years 2017-2018, 2018-2019, and 2020-2021.
- Focused on creating a stimulating educational environment in the Department of Pediatrics, with an emphasis on pediatric hematology/oncology care for infants, children, and adolescents.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Lymphoma
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials William Slayton, MD is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about William Slayton, MD
Clinical Trial Related7 years of experience running clinical trials · Led 57 trials as a Principal Investigator · 26 Active Clinical TrialsTreatments William Slayton, MD has experience with
- Cyclophosphamide
- Etoposide
- Radiation Therapy
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Nivolumab
Breakdown of trials William Slayton, MD has run
Tumors
Lymphoma
Brain Tumor
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Slayton, MD specialize in?
William Slayton, MD focuses on Tumors and Lymphoma. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is William Slayton, MD currently recruiting for clinical trials?
Yes, William Slayton, MD is currently recruiting for 23 clinical trials in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that William Slayton, MD has studied deeply?
Yes, William Slayton, MD has studied treatments such as Cyclophosphamide, Etoposide, Radiation Therapy.
What is the best way to schedule an appointment with William Slayton, MD?
Apply for one of the trials that William Slayton, MD is conducting.
What is the office address of William Slayton, MD?
The office of William Slayton, MD is located at: University of Florida Health Science Center - Gainesville, Gainesville, Florida 32610 United States. This is the address for their practice at the University of Florida Health Science Center - Gainesville.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.